🇺🇸 FDA
Patent

US 11045457

Piperidinyl-3-(aryloxy)propanamides and propanoates

granted A61KA61K31/40A61K31/4355

Quick answer

US patent 11045457 (Piperidinyl-3-(aryloxy)propanamides and propanoates) held by Takeda Pharmaceutical Company Limited expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jun 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/40, A61K31/4355, A61K31/438, A61K31/4439